Ankara Bilkent City Hospital
Ankara, Turkey (Türkiye)
NCT Number: NCT06527417
The aim of this study was to investigate the effect of electromyography (EMG) triggered electrical stimulation (ES) applied to multifidus and erector spinae muscles on trunk balance in patients with complete thoracic spinal cord injury (SCI).
The fundamental questions that investigators want to answer are as follows:
* [question 1]: "Does multifidus and erector spinae EMG ES improve trunk balance in patients with complete SCI?" * [question 2]: "Does multifidus and erector spinae EMG ES improve muscle thickness in patients with complete SCI?"
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Ankara, Turkey (Türkiye)
Spinal cord injury results in loss of sensory and motor function below the level of injury, causing difficulty with unaided sitting and activities of daily living, especially at the thoracic level in SCI patients. The paraspinal muscles that provide trunk balance are weakened in these patients. Methods such as neuromuscular electrical stimulation and EMG ES are used to improve trunk balance and restore muscle function. This study aims to investigate the effect of EMG ES applied to the multifidus and erector spinae muscles on trunk balance in patients with complete thoracic SCI.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Electrical stimulation parameters; stimuli were monophasic, rectangular, stimulus duration 300 µs, frequency 25 Hertz, amplitude was increased up to a maximum of 100 milliampere until contraction was seen.
The control group performed back eccentric exercises for 4 weeks, 3 times a week, 3 times in each session
Time frame: Baseline- Week 4
The trunk control test is a useful tool in determining the prognosis of independence in activities of daily living and measuring trunk balance in individuals with spinal cord injury. It was applied to all participants before and after treatment. The test consisted of 3 parts; static control, dynamic control and dynamic control with upper extremity activities.
Time frame: Baseline- Week 4
The modified functional reach test is a reliable tool to assess sitting reaching in individuals with SCI and to provide immediate feedback to study personnel. It was applied to both groups before and after treatment.
Time frame: Baseline- Week 4
Erector spinae muscle thickness was measured with a real-time B-mode ultrasound device (General Electric Co., Wisconsin, USA). Measurements were performed bilaterally in the prone position with an 8-12 MegaHertz linear probe placed parallel to the muscle fibres. Gel was used between the probe and the skin during the measurements. The measurement site was defined as 7 cm lateral to the L3 spinous process of the lumbar erector spina muscle.
Time frame: Baseline- Week 4
Multifidus muscle thickness was measured with a real-time B-mode ultrasound device (GE, General Electric Co., Wisconsin, USA). Measurements were performed bilaterally in the prone position with an 8-12 MegaHertz linear probe placed parallel to the muscle fibres. Gel was used between the probe and the skin during the measurements. The measurement site was defined as 2 cm lateral to the L4 spinous process of the Multifidus muscle.
Ankara City Hospital Bilkent
Other
The Effect of Electromyography Triggered Electrical Stimulation on Trunk Balance and Muscle Thickness of Multifidus and Erector Spinae Muscles in Patients With Complete Spinal Cord Injury - A Randomised Controlled Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06104982
Central Nervous System Diseases, Nervous System Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT01321333
Central Nervous System Diseases, Nervous System Diseases
Calgary, Alberta, Canada
View Trial DetailsNCT06841770
Bronchial Diseases, Bronchiolitis
Downey, California, United States
View Trial DetailsNCT07135583
Bronchial Diseases, Bronchiolitis
Philadelphia, Pennsylvania, United States
View Trial Details